Sarepta Therapeutics, Inc. (NASDAQ:SRPT) recently saw its volume around 1.63 million shares and on average it trades 1.76 million shares a day. The opening price of $59.16, led it to gain -0.25% to reach $58.99 upon the closing bell.Sarepta Therapeutics, Inc. (SRPT) Analyst Opinion
Sarepta Therapeutics, Inc. has a consensus outperform rating from 19 Wall Street analysts, and the number of shares currently sold short amount to at least 17.04% of shares outstanding. The stock spiked 8.72% last month and is up 6.02 this year. Wall Street is only getting more bullish on the stock, with 18 of analysts who cover SRPT having a buy-equivalent rating. Analysts have placed a $69.78 price target on Sarepta Therapeutics, Inc., suggesting a 18.29% gain from recent close. It’s currently trading about -1.6% below its 52-week high.
Sarepta Therapeutics, Inc. (SRPT) surprised the stock market in its last reported earnings when it earned -$0.76 a piece versus the consensus-estimated -$0.85. Its revenue totaled $40.77 million up 16.45% from the previous quarter.Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Intraday View
This stock (SRPT) is ahead of its 52-week low with 124.64%. Its last month’s stock price volatility remained 6.42% which for the week stands at 3.99%. The share price has moved forward from its 20 days moving average, trading at a distance of 6.07% and stays 8.01% away from its 50 days moving average. Over the last five days, shares have managed 2.04% gains and now is up 40.06% since hitting its 200-day moving average of $46.54. Sarepta Therapeutics, Inc. (SRPT) has made its way to a 12-month gain of 65.94%.
Turning to Teladoc, Inc. (NYSE:TDOC), its shares were trading at $33.2 a gain of $0.1, on the trading floor. The stock, after opening at $33.25, touched a high of $33.85 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.9. Teladoc, Inc. has 6 buy ratings, 3 holds and 0 sells even after the stock tumbled -13.54% from its high of $38.40 to a $1.99 billion market value through last close.
The company’s consensus rating on Reuter’s scale slipped from 1.86 to 1.8 during a month. Analysts set a 12-month price target of $39.77 a share. The target implies a 19.79% spike from where the shares are currently trading. Also, the current price highlights a discount of 44.58% to analysts’ high consensus price target.Teladoc, Inc. (NYSE:TDOC) Intraday Trading
The counter witnessed a trading volume of 1.11 million shares versus an average volume of 1.08 million shares during last trading session. Its last month’s stock price volatility remained 5.33% which for the week approaches 4.18%. The lowest price the stock reached in the last trading day was $33.05 and compares with the $15.65 52-week low. The stock recovered 112.14% since its low point and has performed -4.73% year-to-date.